Cargando…

Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy

BACKGROUND: Genetic and epigenetics factors have been implicated in drug response, graft function and rejection in solid organ transplantation. Differential expression of genes involved in calcineurin and mTOR signaling pathway and regulatory miRNAs was analyzed in the peripheral blood of kidney rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonezi, Vivian, Genvigir, Fabiana Dalla Vecchia, Salgado, Patrícia de Cássia, Felipe, Claudia Rosso, Tedesco-Silva, Helio, Medina-Pestana, José Osmar, Cerda, Alvaro, Doi, Sonia Quateli, Hirata, Mario Hiroyuki, Hirata, Rosario Dominguez Crespo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575939/ https://www.ncbi.nlm.nih.gov/pubmed/33145270 http://dx.doi.org/10.21037/atm-20-1757

Ejemplares similares

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients
por: Campos-Salazar, Antony Brayan, et al.
Publicado: (2018)

Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients
por: Salgado, Patricia C, et al.
Publicado: (2017)

Reviewing 15 years of experience with sirolimus
por: Tedesco Silva, Helio, et al.
Publicado: (2015)

Calcineurin Inhibitors and Neutropenia: Is Cyclosporine Superior to Tacrolimus?
por: Duggal, Tanu, et al.
Publicado: (2019)

The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations
por: Fontova, Pere, et al.
Publicado: (2023)

Long-Term Redistribution of Peripheral Lymphocyte Subpopulations after Switching from Calcineurin to mTOR Inhibitors in Kidney Transplant Recipients
por: Llinàs-Mallol, Laura, et al.
Publicado: (2020)

Early Hospital Readmission (EHR) in kidney transplantation: a review article
por: Tavares, Melissa Gaspar, et al.
Publicado: (2020)

The Calcineurin Inhibitor Tacrolimus Specifically Suppresses Human T Follicular Helper Cells
por: Wallin, Elizabeth F., et al.
Publicado: (2018)

The Role of Calcineurin/NFAT in SFRP2 Induced Angiogenesis—A Rationale for Breast Cancer Treatment with the Calcineurin Inhibitor Tacrolimus
por: Siamakpour-Reihani, Sharareh, et al.
Publicado: (2011)

Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin
por: Cerda, Alvaro, et al.
Publicado: (2011)

Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia
por: Wada, Akira, et al.
Publicado: (2016)

The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension
por: Hoorn, Ewout J., et al.
Publicado: (2011)

STIM1 controls calcineurin/Akt/mTOR/NFATC2-mediated osteoclastogenesis induced by RANKL/M-CSF
por: Huang, Yanjiao, et al.
Publicado: (2020)

Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals
por: de Sandes-Freitas, Tainá Veras, et al.
Publicado: (2015)

Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection
por: Emal, Diba, et al.
Publicado: (2019)

Tacrolimus‐induced hypomagnesemia and hypercalciuria requires FKBP12 suggesting a role for calcineurin
por: Gratreak, Brittany D. K., et al.
Publicado: (2020)

Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40
por: Basu, Aninda, et al.
Publicado: (2011)

Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model
por: Ali, Ahmed Shaker, et al.
Publicado: (2020)

Differential effects of the immunosuppressive calcineurin inhibitors cyclosporine-A and tacrolimus on ovulation in a murine model
por: Zakerkish, F, et al.
Publicado: (2021)

Association of high intra-patient variability in tacrolimus exposure with calcineurin inhibitor nephrotoxicity in kidney transplantation
por: Kim, Hyokee, et al.
Publicado: (2023)

Peripheral Blood miRome Identified miR-155 as Potential Biomarker of MetS and Cardiometabolic Risk in Obese Patients
por: Cerda, Alvaro, et al.
Publicado: (2021)

mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis
por: Xie, Xishao, et al.
Publicado: (2015)

Clinical validation of a liquid chromatography-tandem mass spectrometry method for the quantification of calcineurin and mTOR inhibitors in dried matrix on paper discs
por: Bressán, Ignacio Guillermo, et al.
Publicado: (2022)

Non-melanoma skin cancer outcomes in kidney transplant recipients converted from calcineurin inhibitors to mTOR inhibitors: a systematic review
por: Olszewska, Berenika, et al.
Publicado: (2023)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

The Calcineurin Inhibitor Tacrolimus Reduces Proteinuria in Membranous Nephropathy Accompanied by a Decrease in Angiopoietin-Like-4
por: Peng, Lei, et al.
Publicado: (2014)

Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model [Corrigendum]
Publicado: (2023)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Role of mTOR Signaling in Tumor Microenvironment: An Overview
por: Conciatori, Fabiana, et al.
Publicado: (2018)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Modulation of the mTOR Pathway by Curcumin in the Heart of Septic Mice
por: Rattis, Bruna A. C., et al.
Publicado: (2022)

Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models
por: Shen, Xiujin, et al.
Publicado: (2016)

Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling
por: Rodrigues-Diez, Raquel, et al.
Publicado: (2016)

A Low Tacrolimus Concentration/Dose Ratio Increases the Risk for the Development of Acute Calcineurin Inhibitor-Induced Nephrotoxicity
por: Thölking, Gerold, et al.
Publicado: (2019)

Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death
por: Tosello, Valeria, et al.
Publicado: (2016)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

mTOR Cross-Talk in Cancer and Potential for Combination Therapy
por: Conciatori, Fabiana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5i1d7facdottims05ethjuq8uh